Background. According to the national registries of European countries and epidemiological studies, the prevalence of chronic heart failure (CHF) among adults is 2,0-5,0%, and increases due to age, in people aged over 70 years old it is 10,0-20,0%.
Introduction
According to the national registries of European countries and epidemiological stu dies, prevalence of chronic heart failure (CHF) among adults is 2.0-5.0%, and increases in proportion to age, people aged over 70 years it is from 10.0 to 20.0% [16] . Considering demo graphic trends, in Ukraine as well, to increase the number of population of older age groups, the provision of medical care to patients with CHF is becoming a topical issue [2, 14] .
Distinguish systolic and diastolic options of CHF. In version of systolic CHF the presence of clinical signs in patients with ejection fraction (EF) of LV≤45.0%, at diastolic version with LV EF>45.0% is observed [4] . It is known that left ventricular hypertrophy (LVH) precedes the development of CHF and is formed together INTERNAL mEdIcINE ISSN 2413-6077. IJmmR 2016 Vol. 2 Issue 2 with or even is caused by this disease. Analysis of prognostic value of LVH in patients with CHF with preserved ejection fraction proves that the high risk of lethal outcome is observed in patients with left ventricular myocardial mass that exceeds 400 g [3] . It is established that at the progression of diastolic dysfunction an increased risk of sudden cardiac death in 80.0% occurs [4, 15] . Endothelial dysfunction is very important in development of CHF. The cause of nitric oxide (NO) synthesis inhibition by endo thelium as a major component of its dysfunction at CHF is free radical stress [11] . The main cause of CHF is negative impact of free radical factors that leads to lower ventricular myocardial contractile function followed by entire body hypoxia, endothelial dysfunction with the appropriate activation of cellular factors [17] . These processes can lead to increasing of blood coagulation capacity, which is one of the causes of thrombotic complications in patients with CHF [12] . Biosynthesis of NO from Larginine occurs in three major isoforms of NOsynthase, two constitutive: neuronal (nNOS) and endo thelial (eNOS), and inducible one (iNOS) [6] .
The objective of the study is to find out the specific features of left atrium remodeling and vasodilation factors changes in case of ischemic heart failure with reduced and preserved left ventricular ejection fraction and to establish correlation relationships.
Materials and methods
To achieve this objective a full clinical examination of 153 patients with CHF (105 men and 48 women) was conducted; they were treated in the Department of Cardiology for patients with arrhythmias of Vinnitsa Regional Centre of Cardiovascular Disorders (Ukraine). All patients were divided into 2 groups: group 1 consisted of patients with stable coronary heart disease complicated by heart failure with reduced LV EF (n=47); group 2 -patients with stable coronary heart disease complicated by heart failure with preserved LV EF (n=106). The control group consisted of 30 healthy individuals. The diagnoses of CH and FC was made due to clinical, laboratory and instrumental criteria, as recommended by the European Society of Cardiology (2012) and the Association of Cardiologists of Ukraine (2012) [16] . Diagnosis and treatment of clinical forms of coronary artery disease were made by order of the Ministry of Health of Ukraine № 152 from 03.02.2016 [9] ; functional class (FC) CH -by NYHA classification.
The criteria for inclusion. Patients with stable coronary artery disease IIIII FC followed by CHF IIIII FC on informed consent to participate in the study. Exclusion criteria: CHF FC IV by the NYHA; period up to 3 months from the begin ning of acute myocardial infarction, or stroke; implanted artificial pacemaker or need of im plantation; severe diseases of respiratory system, kidneys, liver with hepatic insufficiency, anaemic state of haemoglobin 90,0 g/dL and below; the formation of malignant disorders and severe neuropsychiatric disorders.
Among the patients who participated in the study mail prevailed. 
Results and Discussion
The decrease in left atrium (LA) dilation degree in patients with stable coronary heart disease complicated by heart failure with reduced and preserved LV EF is presented in Table 1 .
In Table 1 the 1 st group of the examined pa tients with reduced LV EF prevails III (sig nificant) degree of LA dilatation in 33 (70.21%) cases, II (moderate) degree of LA dilatation in 14 (29.78%), I (initial) degree is not defined at all. In the 2 nd group of patients with preserved LV EF the de gree of dilatation II LA was deter mined in 44 (44.51%) cases, and slightly de creased degree of LA dilation in 39 (36.79%) cases (p<0,01), III de gree of LA dilation in 23 (21,69%) cases (p<0,01). Remodeling of myocardium, including hypertrophy and dilation of left ventricle with a changes of its geometry and a contraction violation precedes clinical skim CHF manifes tations [7] . Thus, remodeling is a harbinger of heard activity decompensation [7, 13] . The features of myocardial remodeling are studied the most in patients after myocardial infarction with heart failure development [7, 8, 14] .
These results are consistent with the data that myocardial ischemia may be accompanied by its dysfunction [7] .
The study of factors of vasodilation levels and degrees of LA dilatation in patients with stable coronary heart disease complicated by heart failure with reduced and preserved LV EF is presented in Table 2 .
In patients with stable coronary heart disease complicated by heart failure with reduced LV EF and II degree of LA dilatation, eNOS levels in the serum is 449.00±39.91 pg/ml, whereas in patients with stable coronary heart disease complicated by heart failure with pre served LV EF and II stage of LA dilatation -673.56±50.98 pg/ml (p<0.01). At III stage of LA dilatation in patients of group 1 the eNOS level is 344.20±51.98 pg/ml in patients of groups 2 -616.90±36.49 pg/ml (p<0,01). At the same degree and with LA dilation in patients of group 2 eNOS is 750.27±99.85 pg/ml. Thus, in the examined patients with the progression of heart failure the endothelial factors decrease, e.g. eNOS.
In the study of levels of metabolites of nitrogen monoxide -nitrites and nitrates in blood serum the following data were obtained: in patients with stable coronary heart disease, complicated by heart failure with reduced LV EF and II and III stage of LA dilatation, the total level of nitrates and nitrites in serum was significantly lower than in patients with stable coronary heart disease, complicated by heart failure with preserved LVEF and II and III stage of LA dilatation (p<0.01).
Among the patients of group 1with reduced LV EF with the progression of LA dilation degree from II (moderate) stage to III (large) one, eNOS levels in blood serum decreased by 23.34%. Among the patients of group 2 with preserved LV EF with the progression of LA dilatation from I (initial) stage to II one, the level of eNOS in blood serum decreased by 12.89%, and with the progression of the II stage to III one LA dilation reduced by 8.41%.
In the examined patients with stable coronary artery disease complicated by heart failure with reduced left ventricular ejection fraction, the correlation analysis between indicators of linear dimensions of LA and eNOS levels in the blood serum a direct correlation of medium strength (r=0.38) (p<0,01) was esta b lished. Carrying out a similar correlation ana ly sis for patients with stable coronary heart di sease complicated by heart failure with pre served LV EF also allowed to establish a direct correlation of weak force (r=0.21) (p<0.01).
Progressive hypertrophy and dilatation of heart was followed by subsequent first diastolic disruption and then systolic ventricular dysfunc tion, increased myocardial oxygen demand, changes in subendocardial blood flow, myo cardial bioenergy disorders and increased risk of lifethreatening ventricular arrhythmias [1] .
Recent research proved instrumental and morphological parallels, so we expand on the remodeling of heart as a single clinical and morphological syndrome that is important for making prognosis in patients with coronary heart disease [18] .
The processes of LA remodeling are defined by the degree of new myocardial damage and the presence of viable myocardium.
Conclusions
In patients with stable coronary heart disease complicated by heart failure with reduced left ventricular ejection fraction III (significant) degree of left atrium dilatation was mainly determined, while in patients with stable coronary heart disease complicated by heart failure with preserved left ventricular ejection fraction II (moderate) degree of left atrium dilation was mainly determined.
In the patients with stable coronary heart disease complicated by heart failure with reduced left ventricular ejection fraction in comparison with the group of patients with preserved left ventricular ejection fraction, the significant reduction of eNOS, nitrites, total of nitrites and nitrates was defined during the study.
The research allowed to establish the direct correlation of medium strength (r=0.38) between parameters of linear left atrial size and eNOS levels in blood serum of the patients with stable coronary artery disease complicated by heart failure with reduced left ventricular ejection fraction (p<0.01) and the direct correlation of weak force (r=0.21) in the examined patients with stable coronary artery disease complicated by heart failure with preserved left ventricular ejection fraction (p<0,01).
